Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study)

Zdenek Seidl, J. Vymazal, M. Mechl, M. Goyal, M. Herman, Cesare Colosimo, M. Pasowicz, R. Yeung, B. Paraniak-Gieszczyk, B. Yemen, N. Anzalone, A. Citterio, G. Schneider, S. Bastianello, J. Ruscalleda

Risultato della ricerca: Contributo in rivistaArticolo in rivista

28 Citazioni (Scopus)

Abstract

Gadobenate dimeglumine has proved advantageous compared with other gadolinium-based contrast agents for contrast-enhanced brain MR imaging. Gadobutrol is a more highly concentrated agent (1.0 mol/L). This study intraindividually compared 0.1-mmol/kg doses of these agents for qualitative and quantitative evaluation of brain tumors.
Lingua originaleEnglish
pagine (da-a)1050-1058
Numero di pagine9
RivistaAJNR. American journal of neuroradiology
Volume33
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • Adult
  • Aged
  • Brain Neoplasms
  • Contrast Media
  • Czech Republic
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Meglumine
  • Middle Aged
  • Observer Variation
  • Organometallic Compounds
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Young Adult

Fingerprint

Entra nei temi di ricerca di 'Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study)'. Insieme formano una fingerprint unica.

Cita questo